Cervantes-Madrid, Diana http://orcid.org/0000-0003-1071-1407
Szydzik, Joanna
Lind, Dan Emil http://orcid.org/0000-0002-8299-5659
Borenäs, Marcus
Bemark, Mats http://orcid.org/0000-0001-7416-9819
Cui, Jean
Palmer, Ruth Helen
Hallberg, Bengt http://orcid.org/0000-0003-2032-2616
Article History
Received: 7 February 2019
Accepted: 14 November 2019
First Online: 18 December 2019
Competing interests
: Jean Cui is employed by Turning Point Therapeutics, stock owner of Turning Point Therapeutics. All other authors declare no potential conflict of interest.